SecBot SecBot
6-K ·Filed Sep 28, 2026

IVA

Inventiva S.A.
MIXED
Impact 6/10
Horizonweeks Processed29d 2h ago SEC0001104659-26-111143
Notable filing: 6-K
Actionable Insight ◆ Mixed

The NATiV3 topline readout in Q4 2026 is the sole material catalyst — positive results could unlock T3 warrant exercise (€116M) and Tranche C debt (€55M), extending runway to Q1 2028. Failure to meet the primary composite endpoint would trigger an event of default under the BlackRock/Claret debt. The stock is a binary option on this readout.

DirectionMixed
Confidencehigh
Horizonweeks
Latest settled — T+20d
IVA ▲ +3.68% at T+20d
NEUTRAL call +3.68% · α vs SPY +3.71% · entry $3.53 → $3.66
Next anchor: T+60d in 8w
Entry = T+0 close
Sep 28, 2026
via day close
T+1d
-6.80%
call -6.80% · α -6.61%
$3.29
settled 28d ago
T+5d
-1.42%
call -1.42% · α -2.62%
$3.48
settled 22d ago
T+20d
+3.68%
call +3.68% · α +3.71%
$3.66
settled yesterday
T+60d
Pending
in 8w

Price Chart

Loading chart...

Executive Summary

Inventiva reported H1 2026 financial results showing a net loss of €69.5 million, improved from €175.9 million in H1 2025, primarily due to non-cash fair value gains from the restructuring of EIB warrants. Revenue was minimal at €20,000 versus €4.5 million in H1 2025. The company completed a comprehensive refinancing in June 2026, including a $120M equity offering, repayment of the EIB loan, and a new $75M debt facility from BlackRock/Claret. Cash and cash equivalents stood at €166.1M with €67.8M in short-term deposits, providing runway through Q2 2027, but the company explicitly states a going concern uncertainty exists. The critical binary catalyst is the NATiV3 Phase 3 topline readout expected in Q4 2026.

Key Facts

  • Net loss of €69.5 million in H1 2026 vs €175.9 million in H1 2025
  • Revenue collapsed to €20,000 from €4.5 million in H1 2025
  • Cash and cash equivalents of €166.1 million plus €67.8 million in short-term deposits as of June 30, 2026
  • Completed $120M equity offering (27.3M ADS at $4.40) and $75M debt financing from BlackRock/Claret in June 2026
  • Repaid €62.2M EIB loan and repurchased Legacy EIB Warrants for €50M
  • NATiV3 Phase 3 topline results expected in Q4 2026; last patient completed final 72-week visit on September 2, 2026
  • Company states current cash insufficient to cover operating needs for next 12 months — going concern uncertainty
  • Operating expenses increased 18% to €71.1M driven by R&D (€46.2M), G&A (€22.2M), and pre-commercial costs (€2.6M)
  • Share count increased to 236.3M shares from 193.2M at year-end 2025; fully diluted could reach ~433.6M with T3 warrants

Financial Impact

Net loss improved by €106.4M to €69.5M due to €68.5M non-cash fair value gain on EIB warrant restructuring; cash burn of €45.5M operating cash flow; €233.9M total liquidity (cash + short-term deposits

revenuenet losscashdebtdilution

Risk Factors

  • Going concern risk — current cash insufficient for 12 months without additional financing
  • NATiV3 trial failure would trigger default under debt covenants and likely force restructuring or bankruptcy
  • Massive dilution from outstanding warrants (T3, EIB, Lenders, stock options) — fully diluted shares could reach ~433.6M shares
  • Revenue decline of 99.5% vs prior period with no near-term product revenue expected
  • High debt service costs (€20M interest in H1 2026) with restrictive covenants on IP and cash accounts

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-111143
Document: iva-ex99d2.htm0001104659-26-111143
Document: iva-ex99d3.htm0001104659-26-111143
Document: iva-20260630x6k.htm0001104659-26-111143
Document: 0001104659-26-111143-index-headers.html0001104659-26-111143
Document: 0001104659-26-111143-index.html0001104659-26-111143
Document: 0001104659-26-111143.txt0001104659-26-111143
6 reports for IVA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IVA — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
6-K
NEUTRAL ★ 3/10
$3.37awaiting T+20—$3.77 (+11.89%)
Sep 28, 2026
29d ago
6-K
MIXED ★ 6/10
$3.53 $3.66▲ +3.68%▲ +3.71%$3.77 (+6.66%)
Sep 3, 2026
7w ago
6-K
BULLISH ★ 7/10
$4.84 $3.56▼ −26.45%▼ −25.26%$3.77 (−22.21%)
Jul 6, 2026
16w ago
6-K
NEUTRAL ★ 2/10
$3.90 $4.48▲ +14.87%▲ +15.44%$3.77 (−3.46%)
Jun 12, 2026
19w ago
6-K
MIXED ★ 6/10
$3.76 $4.30▲ +14.36%▲ +15.11%$3.77 (+0.13%)
Jun 12, 2026
19w ago
6-K
NEUTRAL ★ 3/10
$3.85 $4.30▲ +11.69%▲ +9.91%$3.77 (−2.21%)
Showing 6 of 6

US Market Status

Market Open — Closes in 6h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 28, 2026